ACXP News and Press, Acurx Pharmaceuticals Inc. From 03/07/25

Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering PR Newswire STATEN ISLAND, N.Y. , March 7, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company dev...

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics Canada NewsWire First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ) to other anti-CDI ant...

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , Feb. 28, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Ac...

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI Canada NewsWire Major finding provides mechanistic explanation for ibezapolstat's (IBZ) selectivity in that the pre...

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors PR Newswire STATEN ISLAND, N.Y. , Feb. 19, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company devel...

2025-01-31 16:28:10 ET More on Acurx Pharmaceuticals Acurx Pharmaceuticals, Inc. (ACXP) Q3 2024 Earnings Call Transcript Acurx Pharmaceuticals announces $2.5 million registered direct offering Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals Histo...

Issued on behalf of Spearmint Resources Inc. VANCOUVER – USA News Group – As the inauguration of U.S. President Re-Elect Donald Trump draws near, a growing number of businesses are pivoting toward cryptocurrencies , shifting their focus from traditional treasury as...

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire STATEN ISLAND, N.Y. , Jan. 7, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Com...

2025-01-06 17:52:11 ET More on Acurx Pharmaceuticals Acurx Ready To Expand Pipeline With Anthrax Treatment Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals Historical earnings data for Acurx Pharmaceuticals Financial information for Acurx Pharmace...

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire STATEN ISLAND, N.Y. , Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a l...